Mexico - Delayed Quote MXN
Regeneron Pharmaceuticals, Inc. (REGN.MX)
11,620.03
0.00
(0.00%)
At close: April 30 at 1:32:38 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 17 | 25 | 23 |
| Avg. Estimate | 3.29B | 3.43B | 13.47B | 14.3B |
| Low Estimate | 3.11B | 3.17B | 12.6B | 12.73B |
| High Estimate | 3.51B | 3.68B | 14.63B | 15.4B |
| Year Ago Sales | 3.55B | 3.72B | 14.2B | 13.47B |
| Sales Growth (year/est) | -7.19% | -7.94% | -5.16% | 6.17% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| REGN.MX | -- | -- | -- | -- |
| S&P 500 | 13.21% | 2.76% | 7.83% | 13.78% |
Upgrades & Downgrades
| Upgrade | Citigroup: Neutral to Buy | 5/14/2025 |
| Maintains | Guggenheim: Buy to Buy | 5/1/2025 |
| Maintains | Truist Securities: Buy to Buy | 4/30/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 4/30/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 4/30/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 4/30/2025 |